B. Metzler seel. Sohn & Co’s NuVasive, Inc. NUVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-20,476
Closed -$844K 757
2022
Q4
$844K Hold
20,476
0.01% 460
2022
Q3
$897K Buy
20,476
+712
+4% +$34.5K 0.02% 440
2022
Q2
$972K Hold
19,764
0.02% 441
2022
Q1
$1.12M Buy
+19,764
New +$1.05M 0.02% 450

Other funds holding NUVA

B. Metzler seel. Sohn & Co's NUVA Position: Q1 2023 in Review

B. Metzler seel. Sohn & Co sold out of NuVasive, Inc. (NUVA) in Q1 2023, closing a stake of 20,476 shares — an estimated $844K sold.

B. Metzler seel. Sohn & Co first reported a position in NUVA in Q1 2022 and held it in 4 quarters. The position peaked at $1.12M in Q1 2022. 241 funds tracked by Wall St. Rank hold NUVA as of Q1 2023.

  • B. Metzler seel. Sohn & Co reported no remaining NuVasive, Inc. position as of Q1 2023 after selling out during the quarter.
  • B. Metzler seel. Sohn & Co sold 20,476 NuVasive, Inc. shares in Q1 2023, an estimated $844K.
  • B. Metzler seel. Sohn & Co first reported a position in NuVasive, Inc. in Q1 2022 and held it in 4 quarters.
  • B. Metzler seel. Sohn & Co's NuVasive, Inc. position peaked at $1.12M in Q1 2022.
  • 241 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q1 2023.

Based on B. Metzler seel. Sohn & Co's 13F filing for Q1 2023, filed 10 May 2023.